Did Novartis Employees “Willfully” Use Rigged Data in Diovan Ads? Statute of Limitations Will Pose Hurdles to Chase Key Figure

Six months after a data manipulation scandal surfaced for Novartis Pharma’s blood pressure drug Diovan (valsartan), the mystery-shrouded saga took a new turn on January 9 as Japan’s health ministry moved to file a criminal complaint against the company over...read more